<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Infection and Immunity</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Infection and Immunity</journal-title><trans-title-group xml:lang="ru"><trans-title>Инфекция и иммунитет</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2220-7619</issn><issn publication-format="electronic">2313-7398</issn><publisher><publisher-name xml:lang="en">SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">15641</article-id><article-id pub-id-type="doi">10.15789/2220-7619-FCT-15641</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">From coronaviruses to coronaviruses</article-title><trans-title-group xml:lang="ru"><trans-title>От коронавирусов к коронавирусам</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kiseleva</surname><given-names>Irina V.</given-names></name><name xml:lang="ru"><surname>Киселева</surname><given-names>Ирина Васильевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>DSc (Biology), Professor, Head of the Laboratory of General Virology</p></bio><bio xml:lang="ru"><p>д.б.н., профессор, зав. лабораторией общей вирусологии</p></bio><email>irina.v.kiseleva@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3050-1936</contrib-id><name-alternatives><name xml:lang="en"><surname>Musaeva</surname><given-names>Tamila D.</given-names></name><name xml:lang="ru"><surname>Мусаева</surname><given-names>Тамила Даировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Junior Researcher, Laboratory of Molecular Virology, Department of Etiology and Epidemiology</p></bio><bio xml:lang="ru"><p>младший научный сотрудник лаборатории молекулярной вирусологии отдела этиологии и эпидемиологии </p></bio><email>tamilamusaeva94@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Institute of Experimental Medicine</institution></aff><aff><institution xml:lang="ru">ФГБНУ Институт экспериментальной медицины</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Smorodintsev Research Institute of Influenza</institution></aff><aff><institution xml:lang="ru">ФГБУ НИИ гриппа им. А.А. Смородинцева Минздрава России</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2023-11-13" publication-format="electronic"><day>13</day><month>11</month><year>2023</year></pub-date><pub-date date-type="pub" iso-8601-date="2023-11-30" publication-format="electronic"><day>30</day><month>11</month><year>2023</year></pub-date><volume>13</volume><issue>5</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>822</fpage><lpage>840</lpage><history><date date-type="received" iso-8601-date="2023-09-09"><day>09</day><month>09</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-11-05"><day>05</day><month>11</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2023, Kiseleva I.V., Musaeva T.D.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2023, Киселева И.В., Мусаева Т.Д.</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="en">Kiseleva I.V., Musaeva T.D.</copyright-holder><copyright-holder xml:lang="ru">Киселева И.В., Мусаева Т.Д.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://iimmun.ru/iimm/article/view/15641">https://iimmun.ru/iimm/article/view/15641</self-uri><abstract xml:lang="en"><p>The official history of the discovery of human coronaviruses dates back to 1965, when the first coronavirus B814, which has now been lost, was isolated on the human embryonic tracheal organ culture from the nasal swabs of a patient with acute respiratory disease. However, this time point can only be an intermediate stage on its long evolutionary path. Paleovirological studies have shown that coronaviruses could have appeared as early as in the Stone Age — in the Upper Paleolithic era, and East Asia is considered as their place of origin — a region that is well known to virologists as the source of many highly pathogenic influenza viruses and new coronaviruses, such as SARS-CoV, MERS-CoV, and SARS-CoV-2. This makes us take a different look at the seeming “innocence” of seasonal coronaviruses that circulated before 2002, when a human pathogenic virus appeared that caused SARS. This also fits well into the assumption about the coronavirus nature of the 1889 Russian flu pandemic. Today, four seasonal and three new, pathogenic for human coronaviruses are known. Two seasonal coronaviruses (229E and NL63) belong to the genus Alphacoronavirus, 2 others (OC43 and HKU1) and three new coronaviruses (SARS, MERS and SARS-CoV-2) belong to the genus Betacoronavirus. In this review, we have focused on the “extreme points” — seasonal coronaviruses and pandemic SARS-CoV-2. We attempted to draw an analogy between them and identify their main distinguishing features. From the viewpoint of epidemiology and clinic, common what they have is only the airborne transmission route, characteristic of all respiratory viruses, and the ubiquitous distribution, the nature and intensity of which were not markedly affected by the influenza epidemics/pandemics. Seasonal coronaviruses continued to circulate even during the COVID-19 pandemic, when the majority of other respiratory viruses had largely disappeared. Significant differences between seasonal coronaviruses and SARS-CoV-2 can be traced in the symptoms, severity and pathogenesis of the diseases they cause. At the structural level, they have a lot common features including taxonomic proximity, morphology, structure, physicochemical properties of virions, genome organization, the main stages of virus replication, etc. What made SARS-CoV-2 such aggressive? The few differences in the size of viral particles and viral genome that have been identified to date, the use or not of hemagglutinin esterase to penetrate into a sensitive cell, attachment to different cell receptors cannot underlie a prominent difference in severity of the infection caused by seasonal or pandemic coronavirus. Most likely, that these differences are based on delicate molecular mechanisms that have yet to be discovered.</p></abstract><trans-abstract xml:lang="ru"><p>Официальная история открытия коронавирусов человека отсчитывается с 1965 г., когда на органной культуре трахеи человеческого эмбриона из назальных смывов больного острым респираторным заболеванием был выделен первый коронавирус B814, к настоящему времени утерянный. Однако эта дата может являться только промежуточным этапом на длинном эволюционном пути этого возбудителя. Исследования палеовирусологов показали, что коронавирусы могли появиться еще в каменном веке — в эпоху верхнего палеолита, и местом их происхождения называют Восточную Азию — регион, хорошо известный вирусологам как источник появления многих высокопатогенных вирусов гриппа и новых коронавирусов, таких как SARS-CoV, MERS-CoV и SARS-CoV-2. Это заставляет по-иному взглянуть на кажущуюся безобидность сезонных коронавирусов, циркулировавших до 2002 г., когда появился патогенный для человека вирус, вызывавший SARS — атипичную пневмонию. Сюда же укладывается и предположение о коронавирусной природе пандемии русского гриппа 1889 г. Сегодня известны 4 сезонных коронавируса и 3 новых, высокопатогенных для человека. 2 сезонных коронавируса (229E и NL63) относят к роду <italic>Alphacoronavirus</italic>, 2 других (OC43 и HKU1) и 3 новых коронавируса (SARS-CoV, MERS-CoV и SARS-CoV-2) — к роду <italic>Betacoronavirus</italic>. В настоящем обзоре мы остановились на «крайних точках» — сезонных коронавирусах и пандемическом SARS-CoV-2. Мы попытались провести аналогию между ними и выявить основные черты, их отличающие. С точки зрения эпидемиологии и клиники их объединяет только воздушно-капельный путь передачи, характерный для всех респираторных вирусов, и повсеместное распространение, на характер и интенсивность которого не оказывают существенного влияния ни эпидемии, ни пандемии гриппа. Сезонные коронавирусы циркулировали даже в пандемию COVID-19, когда значительная часть других респираторных вирусов практически исчезла. Значительные различия между сезонными коронавирусами и SARS-CoV-2 прослеживаются в симптомах, тяжести и патогенезе заболеваний, которые они вызывают, а на структурном уровне между ними очень много общего. Это таксономическая близость, морфология, строение, физико-химические свойства вирионов, организация генома, основные этапы репликации вируса и многое другое. Что же сделало SARS-CoV-2 настолько агрессивным? Те немногие выявленные к настоящему моменту различия в размерах вирусных частиц и вирусного генома, использование или нет гемагглютининэстеразы для проникновения вируса в чувствительную клетку, прикрепление к разным клеточным рецепторам не могут объяснить существенную разницу в тяжести течения инфекции, которая вызывается сезонным либо пандемическим коронавирусом. Скорее всего, эти различия имеют в своей основе тонкие молекулярные механизмы, о которых еще только предстоит узнать.</p></trans-abstract><kwd-group xml:lang="en"><kwd>acute respiratory infections</kwd><kwd>respiratory viruses</kwd><kwd>human coronaviruses</kwd><kwd>seasonal coronaviruses</kwd><kwd>pandemic SARS-CoV-2</kwd><kwd>features of coronaviruses circulation</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>острые респираторные инфекции</kwd><kwd>респираторные вирусы</kwd><kwd>коронавирусы человека</kwd><kwd>сезонные коронавирусы</kwd><kwd>пандемический SARS-CoV-2</kwd><kwd>особенности циркуляции коронавирусов</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Иванова Н.А., Гринбаум Е.Б., Шадрин А.С., Олейникова Е.В., Попова Т.Л., Лузянина Т.Я., Маслова М.И. Новый вариант вируса А2-Гонконг — возбудитель эпидемии 1968 года в Ленинграде. В кн.: Этиология и диагностика вирусных острых респираторных заболеваний: cб. науч. работ. Ленинград: ВНИИ гриппа, 1971. С. 5–13. [Ivanova N.A., Grinbaum E.B., Shadrin A.S., Oleinikova E.V., Popova T.L., Luzyanina T.Ya., Maslova M.I. A new variant of the A2-Hong Kong virus is the causative agent of the 1968 epidemic in Leningrad. In: Etiology and diagnosis of viral acute respiratory diseases: collection of scientific works. Leningrad: Research Institute of Influenza, 1971, pp. 5–13. (In Russ.)]</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Киселева И.В., Ларионова Н.В., Григорьева Е.П., Ксенафонтов А.Д., Аль Фаррух М., Руденко Л.Г. Особенности циркуляции респираторных вирусов в пред- и пандемические по гриппу и COVID-19 периоды // Инфекция и иммунитет. 2021. Т. 11, №. 6. С. 1009–1019. [Kiseleva I.V., Larionova N.V., Grigorieva E.P., Ksenafontov A.D., Al Farroukh M., Rudenko L.G. Salient features of circulation of respiratory viruses in the pre- and pandemic influenza and COVID-19 seasons.Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2021, vol. 11, no. 6, pp. 1009–1019. (In Russ.)] doi: 10.15789/2220-7619-SFO-1662</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Кононенко А.А., Носков А.К., Водяницкая С.Ю., Подойницына О.А. Коронавирусы человека, способные вызывать чрезвычайные ситуации // Медицинский вестник Юга России. 2021. Т. 12, № 1. С. 14–23. [Kononenko A.A., Noskov A.K. Vodyanitskaya S.Yu., Podoynitsyna O.A. Human coronaviruses that can cause emergencies. Meditsinskii vestnik Yuga Rossii = Medical Bulletin of the South of Russia, 2021, vol. 12, no. 1, pp. 14–23. (In Russ.)] doi: 0.21886/2219-8075-2021-12-1-14-23</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Смирнов В.С., Петленко С.В. Грипп и острые респираторные вирусные инфекции (характеристика, патогенез, профилактика и лечение); изд. 3-е, перераб. и доп. СПб.: Гиппократ, 2019. 248 c. [Smirnov V.S., Petlenko S.V. Influenza and acute respiratory viral infections (Characteristics, pathogenesis, prevention and treatment), 3rd ed. St Petersburg: Hippocrates, 2019. 248 p. (In Russ.)]</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Тимченко В.Н., Суховецкая В.Ф., Чернова Т.М., Каплина Т.А., Субботина М.Д., Булина О.В., Писарева М.М. Результаты 5-летнего мониторинга за циркуляцией сезонных коронавирусов у госпитализированных детей в препандемическом периоде // Детские инфекции, 2021. Т. 20, № 1 (74). С. 5–11. [Timchenko V.N., Sukhovetskaya V.F., Chernova T.M., Kaplina T.A., Subbotina M.D., Bulina O.V., Pisareva M.M. Results of 5-year monitoring of the circulation of seasonal coronaviruses in hospitalized children in the pre-pandemic period. Detskie Infektsii = Children Infections, 2021, vol. 20, no. 1 (74), pp. 5–11. (In Russ.)] doi: 10.22627/2072-8107-2021-20-1-5-11</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Хайтович А.Б. Коронавирусы (таксономия, структура вируса) // Крымский журнал экспериментальной и клинической медицины, 2020, Т. 10, №. 3. С. 69–81. [Khaitovich A.B. Coronaviruses (Taxonomy, virus structure). Krymskii zhurnal eksperimental’noi i klinicheskoi meditsiny = Crimean Journal of Experimental and Clinical Medicine, 2020, vol. 10, no. 3, pp. 69–81. (In Russ.)] doi: 10.37279/2224-6444-2020-10-3-69-81</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Щелканов М.Ю., Попова А.Ю., Дедков В.Г., Акимкин В.Г., Малеев В.В. История изучения и современная классификация коронавирусов (Nidovirales: Coronaviridae) // Инфекция и иммунитет. 2020. Т. 10, № 2. С. 221–246. [Shchelkanov M.Yu., Popova A.Yu., Dedkov V.G., Akimkin V.G., Maleev V.V. History of investigation and current classification of coronaviruses (Nidovirales: Coronaviridae). Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2020, vol. 10, no. 2, pp. 221–246. (In Russ.)] doi: 10.15789/2220-7619-HOI-141</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Яцышина С.Б., Мамошина М.В., Шипулина О.Ю., Подколзин А.Т., Акимкин В.Г. Анализ циркуляции коронавирусов человека // Вопросы вирусологии. 2020. Т. 65, № 5. С. 267–275. [Yatsyshina S.V., Mamoshina M.V., Shipulina O.Yu., Podkolzin A.T., Akimkin V.G. Analysis of human coronaviruses circulation. Voprosy Virusologii = Problems of Virology, 2020, vol. 65, no. 5, pp. 267–275. (In Russ.)] doi: 10.36233/0507-4088-2020-65-5-3</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Akram A., Mannan N. Molecular Structure, pathogenesis and virology of SARS-CoV-2: a review. Bangladesh J. Infect. Dis., 2020, vol. 7, no. suppl_1, pp. S36–S40. doi: 10.3329/bjid.v7i0.46799</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Al Farroukh M., Kiseleva I., Bazhenova E., Stepanova E., Puchkova L., Rudenko L. Understanding the variability of certain biological properties of H1N1pdm09 influenza viruses. Vaccines, 2022, vol. 10, no. 3: 395. doi: 10.3390/vaccines10030395</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Aldridge R.W., Lewer D., Beale S., Johnson A.M., Zambon M., Hayward A.C., Fragaszy E.B.; Flu Watch Group. Seasonality and immunity to laboratory-confirmed seasonal coronaviruses (HCoV-NL63, HCoV-OC43, and HCoV-229E): results from the Flu Watch cohort study. Wellcome Open Res., 2020, vol. 5: 52. doi: 10.12688/wellcomeopenres.15812.2</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Allander T., Tammi M.T., Eriksson M., Bjerkner A., Tiveljung-Lindell A., Andersson B. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc. Natl Acad. Sci. USA, 2005, vol. 102, no. 36, pp. 12891–12896. doi: 10.1073/pnas.0504666102</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Almeida J.D., Berry D.M., Cunningham C.H., Hamre D., Hofstad M.S., Mallucci L., Mcintosh K. Virology: Coronaviruses. Nature, 1968, vol. 220, no. 5168: 650. doi: 10.1038/220650b0</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Audi A., Alibrahim M., Kaddoura M., Hijazi G., Yassine H.M., Zaraket H. Seasonality of respiratory viral infections: will COVID-19 follow suit? Front. Public Health, 2020, vol. 8: 567184. doi: 10.3389/fpubh.2020.567184</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Barupal T., Tak P., Meena M. COVID-19: morphology, characteristics, symptoms, prevention, clinical diagnosis and current scenario. Coronaviruses, 2020, vol. 1, no. 1, pp. 82–89. doi: 10.2174/2666796701999200617161348</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Beams A.B., Bateman R., Adler F.R. Will SARS-CoV-2 become just another seasonal coronavirus? Viruses, 2021, vol. 13, no. 5: 854. doi: 10.3390/v13050854</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Berche P. The enigma of the 1889 Russian flu pandemic: a coronavirus? Presse Med., 2022, vol. 51: 104111. doi: 10.1016/j.lpm.2022.104111</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Bochkov Y.A., Watters K., Ashraf S., Griggs T.F., Devries M.K., Jackson D.J., Palmenberg A.C., Gern J.E. Cadherin-related family member 3, a childhood asthma susceptibility gene product, mediates rhinovirus C binding and replication. Proc. Natl Acad. Sci. USA, 2015, vol. 112, no. 17, pp. 5485–5490. doi: 10.1073/pnas.1421178112</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Brucková M., Mcintosh K., Kapikian A.Z., Chanock R.M. The adaptation of two human coronavirus strains (OC38 and OC43) to growth in cell monolayers. Proc. Soc. Exp. Biol. Med., 1970, vol. 135, no. 2, pp. 431–435. doi: 10.3181/00379727-135-35068</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Brüssow H., Brüssow L. Clinical evidence that the pandemic from 1889 to 1891 commonly called the Russian flu might have been an earlier coronavirus pandemic. Microb. Biotechnol., 2021, vol. 14, no. 5, pp. 1860–1870. doi: 10.1111/1751-7915.13889</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Cabeça T.K., Granato C., Bellei N. Epidemiological and clinical features of human coronavirus infections among different subsets of patients. Influenza Other Respir. Viruses, 2013, vol. 7, no. 6, pp. 1040–1047. doi: 10.1111/irv.12101</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Calderaro A., De Conto F., Buttrini M., Piccolo G., Montecchin S., Maccari C., Martinelli M., Di Maio A., Ferraglia F., Pinardi F., Montagna P., Arcangeletti M.C., Chezzi C. Human respiratory viruses, including SARS-CoV-2, circulating in the winter season 2019–2020 in Parma, Northern Italy. Int. J. Infect. Dis., 2020, vol. 102, pp. 79–84. doi: 10.1016/j.ijid.2020.09.1473</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Callahan Z.Y., Smith T.K., Ingersoll C., Gardner R., Korgenski E.K., Sloan C.D. Comparative seasonal respiratory virus epidemic timing in Utah. Viruses, 2020, vol. 12, no. 3: 275. doi: 10.3390/v12030275</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Callow K.A., Parry H.F., Sergeant M., Tyrrell D.A. The time course of the immune response to experimental coronavirus infection of man. Epidemiol. Infect., 1990, vol. 105, no. 2, pp. 435–446. doi: 10.1017/S0950268800048019</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Chanock R., Roizman B., Myers R. Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). Isolation, properties and characterization. Am. J. Hyg., 1957, vol. 66, no. 3, pp. 281–290. doi: 10.1093/oxfordjournals.aje.a119901</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Chanock R.M. Association of a new type of cytopathogenic myxovirus with infantile croup. J. Exp. Med., 1956, vol. 104, no. 4, pp. 555–576. doi: 10.1084/jem.104.4.555</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Chen A.P., Chu I.Y., Yeh M.L., Chen Y.Y., Lee C.L., Lin H.H., Chan Y.J., Chen H.P. Differentiating impacts of non-pharmaceutical interventions on non-coronavirus disease-2019 respiratory viral infections: Hospital-based retrospective observational study in Taiwan. Influenza Other Respir. Viruses, 2021, vol. 15, no. 4, pp. 478–487. doi: 10.1111/irv.12858</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Chen Y., Liu Q., Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J. Med. Virol., 2020, vol. 92, no. 4, pp. 418–423. doi: 10.1002/jmv.25681</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Chiu S.S., Chan K.H., Chu K.W., Kwan S.W., Guan Y., Poon L.L., Peiris J.S. Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China. Clin. Infect. Dis., 2005, vol. 40, no. 12, pp. 1721–1729. doi: 10.1086/430301</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Chua K.B., Crameri G., Hyatt A., Yu M., Tompang M.R., Rosli J., Mceachern J., Crameri S., Kumarasamy V., Eaton B.T., Wang L.F. A previously unknown reovirus of bat origin is associated with an acute respiratory disease in humans. Proc. Natl Acad. Sci. USA, 2007, vol. 104, no. 27, pp. 11424–11429. doi: 10.1073/pnas.0701372104</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Cimolai N. Complicating infections associated with common endemic human respiratory coronaviruses. Health Secur., 2021, vol. 19, no. 2 , pp. 195–208. doi: 10.1089/hs.2020.0067</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Contini C., Di Nuzzo M., Barp N., Bonazza A., De Giorgio R., Tognon M., Rubino S. The novel zoonotic COVID-19 pandemic: an expected global health concern. J. Infect. Dev. Ctries., 2020, vol. 14, no. 3, pp. 254–264. doi: 10.3855/jidc.12671</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Contrant M., Bigault L., Andraud M., Desdouits M., Rocq S., Le Guyader F.S., Blanchard Y. Porcine epidemic diarrhea virus, surrogate for coronavirus decay measurement in French coastal waters and contribution to coronavirus risk evaluation. Microbiol. Spectr., 2023, vol. 11, no. 4: e0184423. doi: 10.1128/spectrum.01844-23</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Cui J., Li F., Shi Z.L. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol., 2019, vol. 17, no. 3, pp. 181–192. doi: 10.1038/s41579-018-0118-9</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>De Wit E., Van Doremalen N., Falzarano D., Munster V.J. SARS and MERS: recent insights into emerging coronaviruses. Nat. Rev. Microbiol., 2016, vol. 14, no. 8, pp. 523–534. doi: 10.1038/nrmicro.2016.81</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Desforges M., Le Coupanec A., Dubeau P., Bourgouin A., Lajoie L., Dubé M., Talbot P.J. Human coronaviruses and other respiratory viruses: Underestimated opportunistic pathogens of the central nervous system? Viruses, 2020, vol. 12, no. 1: 14. doi: 10.3390/v12010014</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Dowdle W.R. Influenza A virus recycling revisited. Bull. World Health Organ., 1999, vol. 77, no. 10, pp. 820–828. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2557748/pdf/10593030.pdf</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Dyrdak R., Hodcroft E.B., Wahlund M., Neher R.A., Albert J. Interactions between seasonal human coronaviruses and implications for the SARS-CoV-2 pandemic: a retrospective study in Stockholm, Sweden, 2009–2020. J. Clin. Virol., 2021, vol. 136: 104754. doi: 10.1016/j.jcv.2021.104754</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Edridge A.W.D., Kaczorowska J., Hoste A.C.R., Bakker M., Klein M., Loens K., Jebbink M.F., Matser A., Kinsella C.M., Rueda P., Ieven M., Goossens H., Prins M., Sastre P., Deijs M., Van Der Hoek L. Seasonal coronavirus protective immunity is short-lasting. Nat. Med., 2020, vol. 26, no. 11, pp. 1691–1693. doi: 10.1038/s41591-020-1083-1</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Emerman M., Malik H.S. Paleovirology — modern consequences of ancient viruses. PLoS Biol., 2010, vol. 8, no. 2: e1000301. doi: 10.1371/journal.pbio.1000301</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Famoroti T., Sibanda W., Ndung’u T. Prevalence and seasonality of common viral respiratory pathogens, including Cytomegalovirus in children, between 0–5 years of age in KwaZulu-Natal, an HIV endemic province in South Africa. BMC Pediatr., 2018, vol. 18: 240. doi: 10.1186/s12887-018-1222-8</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Farhud D.D., Bahadori M., Zarif-Yeganeh M. Evidence of the ancestries of COVID-19 virus in East Asia, more than 20,000 years ago. Iran J. Public Health, 2021, vol. 50, no. 9, pp. i–v. doi: 10.18502/ijph.v50i9.7086</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Fawkner-Corbett D.W., Khoo S.K., Duarte C.M., Bezerra P.G., Bochkov Y.A., Gern J.E., Le Souef P.N., Mcnamara P.S. Rhinovirus-C detection in children presenting with acute respiratory infection to hospital in Brazil. J. Med. Virol., 2016, vol. 88, no. 1, pp. 58–63. doi: 10.1002/jmv.24300</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Fenner F. Classification and nomenclature of viruses. Second report of the International Committee on Taxonomy of Viruses. Intervirology, 1976, vol. 7, no. 1–2, pp. 1–115. doi: 10.1159/000149938</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Finlayson G., Finlayson S., Finlayson C., Bensusan K., Guillem R., Holmes T., Giles Guzmán F., Carrión J., Belda C., Sawchuk L. Nocturnality, seasonality and the SARS-CoV-2 ecological niche. ArXiv 2010.16167, 2020, vol. 10, no. 19: 39. doi: 10.48550/arXiv.2010.16167</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Francis T.J. A new type of virus from epidemic influenza. Science, 1940, vol. 92, no. 2392, pp. 405–408. doi: 10.1126/science.92.2392.405</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Friedman N., Alter H., Hindiyeh M., Mendelson E., Shemer Avni Y., Mandelboim M. Human Coronavirus infections in Israel: Epidemiology, clinical symptoms and summer seasonality of HCoV-HKU1. Viruses, 2018, vol. 10, no. 10: 515. doi: 10.3390/v10100515</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Fung T.S., Liu D.X. Human coronavirus: Host-pathogen interaction. Annu. Rev. Microbiol., 2019, vol. 73, pp. 529–557. doi: 10.1146/annurev-micro-020518-115759</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Gardinassi L.G., Marques S.P.V., Salomão J.B., Durigon E.L., Zanetta Trevisan D.M., Cordeiro J.A., Lacerda M.N., Rahal P., De Souz F.P. Seasonality of viral respiratory infections in southeast of Brazil: the influence of temperature and air humidity. Braz. J. Microbiol., 2012, vol. 43, no. 1, pp. 98–108. doi: 10.1590/S1517-838220120001000011</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Gaunt E.R., Hardie A., Claas E.C., Simmonds P., Templeton K.E. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J. Clin. Microbiol., 2010, vol. 48, no. 8, pp. 2940–2947. doi: 10.1128/jcm.00636-10</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Ghareeb O., Ramadhan S. COVID-19 — a novel zoonotic disease: origin, prevention and control. P. J. M. H. S., 2021, vol. 15, no. 1, pp. 221–223. URL: https://www.researchgate.net/publication/350709607</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Gorbalenya A.E., Baker S.C., Baric R.S., De Groot R.J., Drosten C., Gulyaeva A.A., Haagmans B.L., Lauber C., Leontovich A.M., Neuman B.W., Penzar D., Perlman S., Poon L.L.M., Samborskiy D.V., Sidorov I.A., Sola I., Ziebuhr J. The species severe acute respiratory syndrome-related coronavirus: classifying 2019–nCoV and naming it SARS-CoV-2. Nat. Microbiol., 2020, vol. 5, no. 4, pp. 536–544. doi: 10.1038/s41564-020-0695-z</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Gordon D.E., Jang G.M., Bouhaddou M., Xu J., Obernier K., White K.M., O’meara M.J., Rezelj V.V., Guo J.Z., Swaney D.L., Tummino T.A., Hüttenhain R., Kaake R.M., Richards A.L., Tutuncuoglu B., Foussard H., Batra J., Haas K., Modak M., Kim M., Haas P., Polacco B.J., Braberg H., Fabius J.M., Eckhardt M., Soucheray M., Bennett M.J., Cakir M., Mcgregor M.J., Li Q., Meyer B., Roesch F., Vallet T., Mac Kain A., Miorin L., Moreno E., Naing Z.Z.C., Zhou Y., Peng S., Shi Y., Zhang Z., Shen W., Kirby I.T., Melnyk J.E., Chorba J.S., Lou K., Dai S.A., Barrio-Hernandez I., Memon D., Hernandez-Armenta C., Lyu J., Mathy C.J.P., Perica T., Pilla K.B., Ganesan S.J., Saltzberg D.J., Rakesh R., Liu X., Rosenthal S.B., Calviello L., Venkataramanan S., Liboy-Lugo J., Lin Y., Huang X.P., Liu Y., Wankowicz S.A., Bohn M., Safari M., Ugur F.S., Koh C., Savar N.S., Tran Q.D., Shengjuler D., Fletcher S.J., O’neal M.C., Cai Y., Chang J.C.J., Broadhurst D.J., Klippsten S., Sharp P.P., Wenzell N.A., Kuzuoglu-Ozturk D., Wang H.Y., Trenker R., Young J.M., Cavero D.A., Hiatt J., Roth T.L., Rathore U., Subramanian A., Noack J., Hubert M., Stroud R.M., Frankel A.D., Rosenberg O.S., Verba K.A., Agard D.A., Ott M., Emerman M., Jura N., von Zastrow M., Verdin E., Ashworth A., Schwartz O., d'Enfert C., Mukherjee S., Jacobson M., Malik H.S., Fujimori D.G., Ideker T., Craik C.S., Floor S.N., Fraser J.S., Gross J.D., Sali A., Roth B.L., Ruggero D., Taunton J., Kortemme T., Beltrao P., Vignuzzi M., García-Sastre A., Shokat K.M., Shoichet B.K., Krogan N.J. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature, 2020, vol. 583, no. 7816, pp. 459–468. doi: 10.1038/s41586-020-2286-9</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Gorse G.J., Patel G.B., Vitale J.N., O’connor T.Z. Prevalence of antibodies to four human coronaviruses is lower in nasal secretions than in serum. Clin. Vaccine. Immunol., 2010, vol. 17, no. 12, pp. 1875–1880. doi: 10.1128/CVI.00278-10</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>GOV.UK. Guidance COVID-19: Epidemiology, virology and clinical features. Updated 17 May 2022. URL: https://www.gov.uk/government/publications/wuhan-novel-coronavirus-background-information/wuhan-novel-coronavirus-epidemiology-virology-and-clinical-features</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Graham N.M. The epidemiology of acute respiratory infections in children and adults: a global perspective. Epidemiol. Rev., 1990, vol. 12, no. 1, pp. 149–178. doi: 10.1093/oxfordjournals.epirev.a036050</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Guan Y., Zheng B.J., He Y.Q., Liu X.L., Zhuang Z.X., Cheung C.L., Luo S.W., Li P.H., Zhang L.J., Guan Y.J., Butt K.M., Wong K.L., Chan K.W., Lim W., Shortridge K.F., Yuen K.Y., Peiris J.S., Poon L.L. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science, 2003, vol. 302, no. 5643, pp. 276–278. doi: 10.1126/science.1087139</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Guo Y.R., Cao Q.D., Hong Z.S., Tan Y.Y., Chen S.D., Jin H.J., Tan K.S., Wang D.Y., Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak — an update on the status. Mil. Med. Res., 2020, vol. 7, no. 1: 11. doi: 10.1186/s40779-020-00240-0</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>Guthmiller J.J., Wilson P.C. Remembering seasonal coronaviruses. Science, 2020, vol. 370, no. 6522, pp. 1272–1273. doi: 10.1126/science.abf48</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>Hamre D., Procknow J.J. A new virus isolated from the human respiratory tract. Proc. Soc. Exp. Biol. Med., 1966, vol. 121, no. 1, pp. 190–193. doi: 10.3181/00379727-121-30734</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>Hawkes M.T., Lee B.E., Kanji J.N., Zelyas N., Wong K., Barton M., Mukhi S., Robinson J.L. Seasonality of respiratory viruses at Northern Latitudes. JAMA Netw. Open, 2021, vol. 4, no. 9: e2124650. doi: 10.1001/jamanetworkopen.2021.24650</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>Heimdal I., Moe N., Krokstad S., Christensen A., Skanke L.H., Nordbø S.A., Døllner H. Human coronavirus in hospitalized children with respiratory tract infections: a 9-year population-based study from Norway. J. Infect. Dis., 2019, vol. 219, no. 8, pp. 1198–1206. doi: 10.1093/infdis/jiy646</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation>Heimdal I., Valand J., Krokstad S., Moe N., Christensen A., Risnes K., Nordbø S.A., Døllner H. Hospitalized children with common human coronavirus clinical impact of codetected respiratory syncytial virus and rhinovirus. Pediatr. Infect. Dis. J., 2022, vol. 41, no. 3, pp. e95–e101. doi: 10.1097/INF.0000000000003433</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation>Hilleman M.R., Werner J.H. Recovery of new agent from patients with acute respiratory illness. Proc. Soc. Exp. Biol. Med., 1954, vol. 85, no. 1, pp. 183–188. doi: 10.3181/00379727-85-20825</mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation>Hoorn B., Tyrrell D.A. A new virus cultivated only in organ cultures of human ciliated epithelium. Arch. Gesamte Virusforsch., 1966, vol. 18, no. 2, pp. 210–225. doi: 10.1007/BF01241842</mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation>Hoorn B., Tyrrel D.A. On the growth of certain “newer” respiratory viruses in organ cultures. Br. J. Exp. Pathol., 1965, vol. 46, no. 2, pp. 109–118.</mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation>Hu B., Guo H., Zhou P., Shi Z.L. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol., 2021, vol. 19, no. 3, pp. 141–154. doi: 10.1038/s41579-020-00459-7</mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation>Huang Y., Yang C., Xu X.F., Xu W., Liu S.W. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol. Sin., 2020, vol. 41, no. 9, pp. 1141–1149. doi: 10.1038/s41401-020-0485-4</mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation>ICTV. 2022 virus taxonomy. URL: https://talk.ictvonline.org/taxonomy</mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation>ICTV. Taxonomic proposal to the ICTV Executive Committee. New species: Betacoronavirus 1. 2008. URL: https://ictv.global/ICTV/proposals/2008.085-122V.v4.Coronaviridae.pdf</mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation>ICTV. Virus Taxonomy. Classification and Nomenclature of Viruses. Report of the International Committee on Taxonomy of Viruses. URL: https://www.academia.edu/8097730/Ninth_Report_of_the_International_Committee_on_Taxonomy_of_Viruses</mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation>Jeon J.H., Han M., Chang H.E., Park S.S., Lee J.W., Ahn Y.J., Hong D.J. Incidence and seasonality of respiratory viruses causing acute respiratory infections in the Northern United Arab Emirates. J. Med. Virol., 2019, vol. 91, no. 8, pp. 1378–1384. doi: 10.1002/jmv.25464</mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation>JHU. COVID-19 dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). 2023. URL: https://coronavirus.jhu.edu/map.html</mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation>Jo W.K., De Oliveira-Filho E.F., Rasche A., Greenwood A.D., Osterrieder K., Drexler J.F. Potential zoonotic sources of SARS-CoV-2 infections. Transbound. Emerg. Dis., 2021, vol. 68, no. 4, pp. 1824–1834. doi: 10.1111/tbed.13872</mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation>Kesheh M.M., Hosseini P., Soltani S., Zandi M. An overview on the seven pathogenic human coronaviruses. Rev. Med. Virol., 2022, vol. 32, no. 2: e2282. doi: 10.1002/rmv.2282</mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation>Khaitovich A., Sataieva T., Zukow W., Malygina V., Shevkoplyas L., Logadyr T., Kirsanova M., Andronovskaya I., Soroka E. The biological diversity of coronaviruses: where will the new threat come from? J. Educ. Health Sport, 2022, vol. 12, no. 5, pp. 402–415. doi: 10.12775/JEHS.2022.12.05.032</mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation>Killerby M.E., Biggs H.M., Haynes A., Dahl R.M., Mustaquim D., Gerber S.I., Watson J.T. Human coronavirus circulation in the United States 2014–2017. J. Clin. Virol., 2018, vol. 101, no. 1, pp. 52–56. doi: 10.1016/j.jcv.2018.01.019</mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation>Kim M.I., Lee C. Human coronavirus OC43 as a low-risk model to study COVID-19. Viruses, 2023, vol. 15, no. 2: 578. doi: 10.3390/v15020578</mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation>Kiseleva I., Grigorieva E., Larionova N., Al Farroukh M., Rudenko L. COVID-19 in light of seasonal respiratory infections. Biology (Basel), 2020, vol. 9, no. 9: 240. doi: 10.3390/biology9090240</mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation>Kiseleva I., Ksenafontov A. COVID-19 shuts doors to flu but keeps them open to rhinoviruses. Biology (Basel), 2021, vol. 10, no. 8: 733. doi: 10.3390/biology10080733</mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation>Kiseleva I., Musaeva T., Ksenafontov A. SARS-CoV-2 invasion: what happens to other respiratory viruses? Open Microbiol. J., 2020, vol. 16, no. 1: e187428582206100. doi: 10.2174/18742858-v16-e2206100</mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation>Komabayashi K., Seto J., Matoba Y., Aoki Y., Tanaka S., Ikeda T., Matsuzaki Y., Itagaki T., Mizuta K. Seasonality of human coronavirus OC43, NL63, HKU1, and 229E infection in Yamagata, Japan, 2010–2019. Jpn J. Infect. Dis., 2020, vol. 73, no. 5, pp. 394–397. doi: 10.7883/yoken.JJID.2020.525</mixed-citation></ref><ref id="B83"><label>83.</label><mixed-citation>Kong D., Zheng Y., Hu L., Chen J., Wu H., Teng Z., Zhou Y., Qiu Q., Lu Y., Pan H. Epidemiological and co-infection characteristics of common human coronaviruses in Shanghai, 2015–2020: a retrospective observational study. Emerg. Microbes. Infect., 2021, vol. 10, no. 1, pp. 1660–1668. doi: 10.1080/22221751.2021.1965498</mixed-citation></ref><ref id="B84"><label>84.</label><mixed-citation>Kuypers J., Martin E.T., Heugel J., Wright N., Morrow R., Englund J.A. Clinical disease in children associated with newly described coronavirus subtypes. Pediatrics, 2007, vol. 119, no. 1, pp. 70–76. doi: 10.1542/peds.2006-1406</mixed-citation></ref><ref id="B85"><label>85.</label><mixed-citation>La Scola B., Audic S., Robert C., Jungang L., De Lamballerie X., Drancourt M., Birtles R., Claverie J.M., Raoult D. A giant virus in amoebae. Science, 2003, vol. 299, no. 5615: 2033. doi: 10.1126/science.1081867</mixed-citation></ref><ref id="B86"><label>86.</label><mixed-citation>Lalchhandama K. The chronicles of coronaviruses: The bronchitis, the hepatitis and the common cold. Sci. Vis., 2020, vol. 20, no. 1, pp. 43–53. doi: 10.33493/scivis.20.01.04</mixed-citation></ref><ref id="B87"><label>87.</label><mixed-citation>Li F. Structure, function, and evolution of coronavirus spike proteins. Annu. Rev. Virol., 2016, vol. 3, no. 1, pp. 237–261. doi: 10.1146/annurev-virology-110615-042301</mixed-citation></ref><ref id="B88"><label>88.</label><mixed-citation>Li W., Shi Z., Yu M., Ren W., Smith C., Epstein J.H., Wang H., Crameri G., Hu Z., Zhang H., Zhang J., Mceachern J., Field H., Daszak P., Eaton B.T., Zhang S., Wang L.F. Bats are natural reservoirs of SARS-like coronaviruses. Science, 2005, vol. 310, no. 5748, pp. 676–679. doi: 10.1126/science.1118391</mixed-citation></ref><ref id="B89"><label>89.</label><mixed-citation>Li Y., Wang X., Nair H. Global seasonality of human seasonal coronaviruses: a clue for postpandemic circulating season of severe acute respiratory syndrome coronavirus 2? J. Infect. Dis., 2020, vol. 222, no. 7, pp. 1090–1097. doi: 10.1093/infdis/jiaa436</mixed-citation></ref><ref id="B90"><label>90.</label><mixed-citation>Liu D., Liang J., Fung T.S. Human Coronavirus-229E, -OC43, -NL63, and -HKU1. Encyclopedia of Virology, 2021, vol. 2, no. 1, pp. 428–440. doi: 10.1016/B978-0-12-809633-8.21501-X</mixed-citation></ref><ref id="B91"><label>91.</label><mixed-citation>Liu L., Wang T., Lu J. The prevalence, origin, and prevention of six human coronaviruses. Virol. Sin., 2016, vol. 31, no. 1, pp. 94–99. doi: 10.1007/s12250-015-3687-z</mixed-citation></ref><ref id="B92"><label>92.</label><mixed-citation>Liu X., Huang J., Li C., Zhao Y., Wang D., Huang Z., Yang K. The role of seasonality in the spread of COVID-19 pandemic. Environ. Res., 2021, vol. 195: 110874. doi: 10.1016/j.envres.2021.110874</mixed-citation></ref><ref id="B93"><label>93.</label><mixed-citation>Liu Y., Lam T.T.Y., Lai F.Y.L., Krajden M., Drews S.J., Hatchette T.F., Fraaij P.L.A., Van Kampen J.J.A., Badarch D., Nymadawa P., Tee K.K., Lee H.K., Koay E.S.C., Jennings L., Koopmans M., Tang J.W. Comparative seasonalities of influenza A, B and “common cold” coronaviruses — setting the scene for SARS-CoV-2 infections and possible unexpected host immune interactions. J. Infect., 2020, vol. 81, no. 2, pp. 62–64. doi: 10.1016/j.jinf.2020.04.032</mixed-citation></ref><ref id="B94"><label>94.</label><mixed-citation>Ljubin-Sternak S., Meštrović T., Lukšić I., Mijač M., Vraneš J. Seasonal coronaviruses and other neglected respiratory viruses: a global perspective and a local snapshot. Front. Public Health, 2021, vol. 9: 691163. doi: 10.3389/fpubh.2021.691163</mixed-citation></ref><ref id="B95"><label>95.</label><mixed-citation>Lowen A.C., Mubareka S., Tumpey T.M., Garcia-Sastre A., Palese P. The guinea pig as a transmission model for human influenza viruses. Proc. Natl Acad. Sci. USA, 2006, vol. 103, no. 26, pp. 9988–9992. doi: 10.1073/pnas.0604157103</mixed-citation></ref><ref id="B96"><label>96.</label><mixed-citation>Lu Q.B., Wo Y., Wang L.Y., Wang H.Y., Huang D.D., Zhang X.A., Liu W., Cao W.C. Molecular epidemiology of human rhinovirus in children with acute respiratory diseases in Chongqing, China. Sci. Rep., 2014, vol. 4: 6686. doi: 10.1038/srep06686</mixed-citation></ref><ref id="B97"><label>97.</label><mixed-citation>Lv L., Li G., Chen J., Liang X., Li Y. Comparative genomic analyses reveal a specific mutation pattern between human coronavirus SARS-CoV-2 and Bat-CoV RaTG13. Front. Microbiol., 2020, vol. 11: 584717. doi: 10.3389/fmicb.2020.584717</mixed-citation></ref><ref id="B98"><label>98.</label><mixed-citation>Mcintosh K., Dees J.H., Becker W.B., Kapikian A.Z., Chanock R.M. Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. Proc. Natl Acad. Sci. USA, 1967, vol. 57, no. 4, pp. 933–940. doi: 10.1073/pnas.57.4.933</mixed-citation></ref><ref id="B99"><label>99.</label><mixed-citation>Menachery V.D., Yount B.L.Jr., Debbink K., Agnihothram S., Gralinski L.E., Plante J.A., Graham R.L., Scobey T., Ge X.Y., Donaldson E.F., Randell S.H., Lanzavecchia A., Marasco W.A., Shi Z.L., Baric R.S. A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence. Nat. Med., 2015, vol. 21, no. 12, pp. 1508–1513. doi: 10.1038/nm.3985</mixed-citation></ref><ref id="B100"><label>100.</label><mixed-citation>Mohd H.A., Al-Tawfiq J.A., Memish Z.A. Middle East respiratory syndrome coronavirus (MERS-CoV) origin and animal reservoir. Virol. J., 2016, vol. 13, no. 1: 87. doi: 10.1186/s12985-016-0544-0</mixed-citation></ref><ref id="B101"><label>101.</label><mixed-citation>Moriyama M., Hugentobler W.J., Iwasaki A. Seasonality of respiratory viral infections. Annu. Rev. Virol., 2020, vol. 7, no. 1, pp. 83–101. doi: 10.1146/annurev-virology-012420-022445</mixed-citation></ref><ref id="B102"><label>102.</label><mixed-citation>Mulder J., Masurel N., Hers J.F.P. The Asian influenza pandemic of 1957. Ned. Tijdschr. Geneeskd., 1958, vol. 102, no. 41, pp. 1992–1999.</mixed-citation></ref><ref id="B103"><label>103.</label><mixed-citation>Myint S.H. Human coronaviruses: a brief review. Rev. Med. Virol., 1994, vol. 4, pp. 35–46. doi: 10.1002/rmv.1980040108</mixed-citation></ref><ref id="B104"><label>104.</label><mixed-citation>Nickbakhsh S., Ho A., Marques D.F.P., Mcmenamin J., Gunson R.N., Murcia P.R. Epidemiology of seasonal coronaviruses: Establishing the context for COVID-19 emergence. J. Infect. Dis., 2020, vol. 222, no. 1, pp. 17–25. doi: 10.1093/infdis/jiaa185</mixed-citation></ref><ref id="B105"><label>105.</label><mixed-citation>Novak N., Cabanillas B. Viruses and asthma: the role of common respiratory viruses in asthma and its potential meaning for SARS-CoV-2. Immunology, 2020, vol. 161, no. 2, pp. 83–93. doi: 10.1111/imm.13240</mixed-citation></ref><ref id="B106"><label>106.</label><mixed-citation>Payne S. Family Coronaviridae. Viruses, 2017, pp. 149–158. doi: 10.1016/b978-0-12-803109-4.00017-9</mixed-citation></ref><ref id="B107"><label>107.</label><mixed-citation>Peng Y., Du N., Lei Y., Dorje S., Qi J., Luo T., Gao G.F., Song H. Structures of the SARS-CoV-2 nucleocapsid and their perspectives for drug design. Embo J., 2020, vol. 39, no. 20: e105938. doi: 10.15252/embj.2020105938</mixed-citation></ref><ref id="B108"><label>108.</label><mixed-citation>Poole S., Brendish N.J., Clark T.W. SARS-CoV-2 has displaced other seasonal respiratory viruses: results from a prospective cohort study. J. Infect., 2020, vol. 81, no. 6, pp. 966–972. doi: 10.1016/j.jinf.2020.11.010</mixed-citation></ref><ref id="B109"><label>109.</label><mixed-citation>Price R.H.M., Graham C., Ramalingam S. Association between viral seasonality and meteorological factors. Sci. Rep., 2019, vol. 9, no. 1: 929. doi: 10.1038/s41598-018-37481-y</mixed-citation></ref><ref id="B110"><label>110.</label><mixed-citation>Price W.H. The isolation of a new virus associated with respiratory clinical disease in humans. Proc. Natl Acad. Sci. USA, 1956, vol. 42, no. 12, pp. 892–896. doi: 10.1073/pnas.42.12.892</mixed-citation></ref><ref id="B111"><label>111.</label><mixed-citation>Rabaan A.A., Al-Ahmed S.H., Haque S., Sah R., Tiwari R., Malik Y.S., Dhama K., Yatoo M.I., Bonilla-Aldana D.K., Rodriguez-Morales A.J. SARS-CoV-2, SARS-CoV, and MERS-COV: a comparative overview. Infez. Med., 2020, vol. 28, no. 2, pp. 174–184.</mixed-citation></ref><ref id="B112"><label>112.</label><mixed-citation>Rodgers L., Sheppard M., Smith A., Dietz S., Jayanthi P., Yuan Y., Bull L., Wotiz S., Schwarze T., Azondekon R., Hartnett K., Adjemian J., Kirking H.L., Kite Powell A. Changes in seasonal respiratory illnesses in the United States during the COVID-19 pandemic. Clin. Infect. Dis., 2021, vol. 73, no. 1, pp. 110–117. doi: 10.1093/cid/ciab311</mixed-citation></ref><ref id="B113"><label>113.</label><mixed-citation>Rowe W.P., Huebner R.J., Gilmore L.K., Parrott R.H., Ward T.G. Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc. Soc. Exp. Biol. Med., 1953, vol. 84, no. 3, pp. 570–573. doi: 10.3181/00379727-84-20714</mixed-citation></ref><ref id="B114"><label>114.</label><mixed-citation>Sampson A.T., Heeney J., Cantoni D., Ferrari M., Sans M.S., George C., Di Genova C., Mayora Neto M., Einhauser S., Asbach B., Wagner R., Baxendale H., Temperton N., Carnell G. Coronavirus pseudotypes for all circulating human coronaviruses for quantification of cross-neutralizing antibody responses. Viruses, 2021, vol. 13, no. 8: 1579. doi: 10.3390/v13081579</mixed-citation></ref><ref id="B115"><label>115.</label><mixed-citation>Sermet I., Temmam S., Huon C., Behillil S., Gadjos V., Bigot T., Lurier T., Chrétien D., Backovick M., Moisan-Delaunay A., Donati F., Albert M., Foucaud E., Mesplées B., Benoist G., Fayes A., Duval-Arnould M., Crétolle C., Charbit M., Aubart M., Auriau J., Lorrot M., Kariyawasam D., Fertita L., Orliaguet G., Pigneur B., Bader-Meunier B., Briand C., Toubiana J., Guilleminot T., van der Werf S., Leruez-Ville M., Eloit M. Prior infection by seasonal coronaviruses does not prevent SARS-CoV-2 infection and associated Multisystem Inflammatory Syndrome in children. Euro Surveill., 2020, vol. 26, no. 13: 2001782. doi: 10.2807/1560-7917.ES.2021.26.13.2001782</mixed-citation></ref><ref id="B116"><label>116.</label><mixed-citation>Shah M.M., Winn A., Dahl R.M., Kniss K.L., Silk B.J., Killerby M.E. Seasonality of common human coronaviruses, United States, 2014–2021. Emerg. Infect. Dis., 2022, vol. 28, no. 10, pp. 1970–1976. doi: 10.3201/eid2810.220396</mixed-citation></ref><ref id="B117"><label>117.</label><mixed-citation>Shaw B., Gatherer D. Candidate historical events for the emergence of Human Coronavirus OC43: a critical reassessment of the molecular evidence. PLoS One, 2023, vol. 18, no. 5: e0285481. doi: 10.1371/journal.pone.0285481</mixed-citation></ref><ref id="B118"><label>118.</label><mixed-citation>Smith W., Andrewes C.H., Laidlaw P.P. A virus obtained from influenza patients. Lancet, 1933, vol. 222, no. 5732, pp. 66–68. doi: 10.1016/S0140-6736(00)78541-2</mixed-citation></ref><ref id="B119"><label>119.</label><mixed-citation>Souilmi Y., Lauterbur M.E., Tobler R., Huber C.D., Johar A.S., Moradi S.V., Johnston W.A., Krogan N.J., Alexandrov K., Enard D. An ancient viral epidemic involving host coronavirus interacting genes more than 20,000 years ago in East Asia. Curr. Biol., 2021, vol. 31, no. 16, pp. 3504–3514. doi: 10.1016/j.cub.2021.05.067</mixed-citation></ref><ref id="B120"><label>120.</label><mixed-citation>St John S.E., Tomar S., Stauffer S.R., Mesecar A.D. Targeting zoonotic viruses: structure-based inhibition of the 3C-like protease from bat coronavirus HKU4 — the likely reservoir host to the human coronavirus that causes Middle East Respiratory Syndrome (MERS). Bioorg. Med. Chem., 2015, vol. 23, no. 17, pp. 6036–6048. doi: 10.1016/j.bmc.2015.06.039</mixed-citation></ref><ref id="B121"><label>121.</label><mixed-citation>Tang D., Comish P., Kang R. The hallmarks of COVID-19 disease. PLoS Pathog., 2020, vol. 16, no. 5: e1008536. doi: 10.1371/journal.ppat.1008536</mixed-citation></ref><ref id="B122"><label>122.</label><mixed-citation>Tang G., Liu Z., Chen D. Human coronaviruses: origin, host and receptor. J. Clin. Virol., 2022, vol. 155, no. 1: 105246. doi: 10.1016/j.jcv.2022.105246</mixed-citation></ref><ref id="B123"><label>123.</label><mixed-citation>Taubenberger J.K., Morens D.M., Fauci A.S. The next influenza pandemic: can it be predicted? JAMA, 2007, vol. 297, no. 18, pp. 2025–2027. doi: 10.1001/jama.297.18.2025</mixed-citation></ref><ref id="B124"><label>124.</label><mixed-citation>Taubenberger J.K., Reid A.H., Krafft A.E., Bijwaard K.E., Fanning T.G. Initial genetic characterization of the 1918 “Spanish” influenza virus. Science, 1997, vol. 275, no. 5307, pp. 1793–1796. doi: 10.1126/science.275.5307.1793</mixed-citation></ref><ref id="B125"><label>125.</label><mixed-citation>Taylor R.M. Studies on survival of influenza virus between epidemics and antigenic variants of the virus. Am. J. Public Health Nations Health., 1949, vol. 39, no. 2, pp. 171–178. doi: 10.2105/ajph.39.2.171</mixed-citation></ref><ref id="B126"><label>126.</label><mixed-citation>Thomas S. Mapping the nonstructural transmembrane proteins of severe acute respiratory syndrome coronavirus 2. J. Comput. Biol., 2021, vol. 28, no. 9, pp. 909–921. doi: 10.1089/cmb.2020.0627</mixed-citation></ref><ref id="B127"><label>127.</label><mixed-citation>Toze S.J., Lambert S.B., Whiley D.M., Bialasiewicz S., Lyon M.J., Nissen M.D., Sloots T.P. Detection of human bocavirus in respiratory, fecal, and blood samples by real-time PCR. J. Med. Virol., 2009, vol. 81, no. 3, pp. 488–493. doi: 10.1002/jmv.21409</mixed-citation></ref><ref id="B128"><label>128.</label><mixed-citation>Tsai S.C., Lu C.C., Bau D.T., Chiu Y.J., Yen Y.T., Hsu Y.M., Fu C.W., Kuo S.C., Lo Y.S., Chiu H.Y., Juan Y.N., Tsai F.J., Yang J.S. Approaches towards fighting the COVID-19 pandemic (Review). Int. J. Mol. Med., 2021, vol. 47, no. 1, pp. 3–22. doi: 10.3892/ijmm.2020.4794</mixed-citation></ref><ref id="B129"><label>129.</label><mixed-citation>Tumpey T.M., Basler C.F., Aguilar P.V., Zeng H., Solorzano A., Swayne D.E., Cox N.J., Katz J.M., Taubenberger J.K., Palese P., Garcia-Sastre A. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science, 2005, vol. 310, no. 5745, pp. 77–80. doi: 10.1126/science.1119392</mixed-citation></ref><ref id="B130"><label>130.</label><mixed-citation>Tyrrell D.A., Bynoe M.L. Cultivation of a novel type of common-cold virus in organ cultures. Br. Med. J., 1965, vol. 1, no. 5448, pp. 1467–1470. doi: 10.1136/bmj.1.5448.1467</mixed-citation></ref><ref id="B131"><label>131.</label><mixed-citation>Valleron A.J., Cori A., Valtat S., Meurisse S., Carrat F., Boëlle P.Y. Transmissibility and geographic spread of the 1889 influenza pandemic. Proc. Natl Acad. Sci. USA, 2010, vol. 107, no. 19, pp. 8778–8781. doi: 10.1073/pnas.1000886107</mixed-citation></ref><ref id="B132"><label>132.</label><mixed-citation>Van Den Hoogen B.G., De Jong J.C., Groen J., Kuiken T., De Groot R., Fouchier R.A., Osterhaus A.D. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat. Med., 2001, vol. 7, no. 6, pp. 719–724. doi: 10.1038/89098</mixed-citation></ref><ref id="B133"><label>133.</label><mixed-citation>Van der Hoek L., Pyrc K., Jebbink M.F., Vermeulen-Oost W., Berkhout R.J.M., Wolthers K.C., Wertheim-van Dillen P.M.E., Kaandorp J., Spaargaren J., Berkhout B. Identification of a new human coronavirus. Nat. Med., 2004. vol. 10, no. 4, pp. 368–373.</mixed-citation></ref><ref id="B134"><label>134.</label><mixed-citation>Varghese L., Zachariah P., Vargas C., LaRussa P., Demmer R.T., Furuya Y.E., Whittier S., Reed C., Stockwell M.S., Saiman L. Epidemiology and clinical features of human coronaviruses in the pediatric population. J. Pediatric Infect. Dis. Soc., 2018, vol. 7, no. 2, pp. 151–158. doi: 10.1093/jpids/pix027</mixed-citation></ref><ref id="B135"><label>135.</label><mixed-citation>Vijgen L., Keyaerts E., Moës E., Thoele I., Wollants E., Lemey P., Vandamme A.M., Van Ranst M. Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event. J. Virol., 2005, vol. 79, no. 3, pp. 1595–1604. doi: 10.1128/JVI.79.3.1595-1604.2005</mixed-citation></ref><ref id="B136"><label>136.</label><mixed-citation>Waterlow N.R., Van Leeuwen E., Davies N.G., Flasche S., Eggo R.M. How immunity from and interaction with seasonal coronaviruses can shape SARS-CoV-2 epidemiology. Proc. Natl Acad. Sci. USA, 2021, vol. 118, no. 49: e2108395118. doi: 10.1073/pnas.2108395118</mixed-citation></ref><ref id="B137"><label>137.</label><mixed-citation>Wen C., Sun L., Zhao M.C., Duan S.X., Wang L., Cui X.W. Clinical study of human coronavirus NL63, OC43, 229E, HKU1 infentions in hospitalized children from 2015 to 2020. Infect. Drug. Resist., 2022, vol. 15, no. 1, pp. 1093–1101. doi: 10.2147/IDR.S357193</mixed-citation></ref><ref id="B138"><label>138.</label><mixed-citation>WHO. Middle East respiratory syndrome coronavirus (MERS-CoV). 2023. URL: https://www.who.int/health-topics/middle-east-respiratory-syndrome-coronavirus-mers#tab=tab_1</mixed-citation></ref><ref id="B139"><label>139.</label><mixed-citation>WHO. Severe Acute Respiratory Syndrome (SARS). 2023. URL: https://www.who.int/health-topics/severe-acute-respiratory-syndrome#tab=tab_1</mixed-citation></ref><ref id="B140"><label>140.</label><mixed-citation>Wong-Chew R.M., Fernández J.A.M. Generalities, clinical and prevention aspects of COVID-19: Mexico and Latin America. Univ. Med., 2021, vol. 62, no. 3, pp. 97–114. doi: 10.11144/javeriana.umed62-3.gacp</mixed-citation></ref><ref id="B141"><label>141.</label><mixed-citation>Woo P.C., Lau S.K., Chu C.M., Chan K.H., Tsoi H.W., Huang Y., Wong B.H., Poon R.W., Cai J.J., Luk W.K., Poon L.L., Wong S.S., Guan Y., Peiris J.S., Yuen K.Y. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J. Virol., 2005, vol. 79, no. 2, pp. 884–895. doi: 10.1128/JVI.79.2.884-895.2005</mixed-citation></ref><ref id="B142"><label>142.</label><mixed-citation>Woo P.C.Y., Huang Y., Lau S.K.P., Yuen K.Y. Coronavirus genomics and bioinformatics analysis. Viruses, 2010, vol. 2, no. 8, pp. 1804–1820. doi: 10.3390/v2081803</mixed-citation></ref><ref id="B143"><label>143.</label><mixed-citation>Yin Y., Wunderink R.G. MERS, SARS and other coronaviruses as causes of pneumonia. Respirology, 2018, vol. 23, no. 2, pp. 130–137. doi: 10.1111/resp.13196</mixed-citation></ref><ref id="B144"><label>144.</label><mixed-citation>Yoshimoto F.K. The proteins of severe acute respiratory syndrome coronavirus-2 (SARS CoV-2 or n-COV19), the cause of COVID-19. Protein J., 2020, vol. 39, no. 3, pp. 198–216. doi: 10.1007/s10930-020-09901-4</mixed-citation></ref><ref id="B145"><label>145.</label><mixed-citation>Zeng Q., Langereis M.A., Van Vliet A.L., Huizinga E.G., De Groot R.J. Structure of coronavirus hemagglutinin-esterase offers insight into corona and influenza virus evolution. Proc. Natl Acad. Sci. USA, 2008, vol. 105, no. 26, pp. 9065–9069. doi: 10.1073/pnas.0800502105</mixed-citation></ref><ref id="B146"><label>146.</label><mixed-citation>Zeyaullah M., Alshahrani A.M., Muzammil K., Ahmad I., Alam S., Khan W.H., Ahmad R. COVID-19 and SARS-CoV-2 variants: current challenges and health concern. Front. Genet., 2021, vol. 12: 693916. doi: 10.3389/fgene.2021.693916</mixed-citation></ref><ref id="B147"><label>147.</label><mixed-citation>Zhao X., Ding Y., Du J., Fan Y. 2020 update on human coronaviruses: one health, one world. Med. Nov. Technol. Devices, 2020, vol. 8: 100043. doi: 10.1016/j.medntd.2020.100043</mixed-citation></ref><ref id="B148"><label>148.</label><mixed-citation>Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W., Si H.R., Zhu Y., Li B., Huang C.L., Chen H.D., Chen J., Luo Y., Guo H., Jiang R.D., Liu M.Q., Chen Y., Shen X.R., Wang X., Zheng X.S., Zhao K., Chen Q.J., Deng F., Liu L.L., Yan B., Zhan F.X., Wang Y.Y., Xiao G.F., Shi Z.L. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 2020, vol. 579, no. 7798, pp. 270–273. doi: 10.1038/s41586-020-2012-7</mixed-citation></ref><ref id="B149"><label>149.</label><mixed-citation>Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., Niu P., Zhan F., Ma X., Wang D., Xu W., Wu G., Gao G.F., Tan W. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med., 2020, vol. 382, no. 8, pp. 727–733. doi: 10.1056/NEJMoa2001017</mixed-citation></ref></ref-list></back></article>
